Biological Evaluation of 2-aminothiazole Hybrid as Antimalarial and Antitrypanosomal Agents: Design and Synthesis

Author(s): Surender S. Jadav, Vishnu N. Badavath*, Ramesh Ganesan, Narayana M. Ganta, Dominique Besson*, Venkatesan Jayaprakash*

Journal Name: Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry

Volume 18 , Issue 2 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: A series of 2-aminothiazole schiff’s bases (1-24) were synthesized and screened against a few neglected tropical disorders (NTDs). Compounds 12 and 14 were found to have antitrypanosidal activity, whereas compound 14 was found to be more effective than standard benznidazole. The antiplasmodial assay provided three specific and effective compounds (9, 12 and 24) than standard chloroquine. Compound (21) inhibited Leishmania infantum, almost similar to Miltefosine.

Methods: All the compounds were subjected to cytotoxicity assay and none of the compounds were found to be cytotoxicity. Molecular docking simulations revealed that four compounds (1, 9, 12 and 21) were found to similarly occupy the hydrophobic active site of trans-2-enoyl acyl carrier protein reductase of P. falciparum (PfENR) as triclosan and outcomes were closely related to their anti-malarial potencies.

Results and Conclusion: The screening results against T. cruzi, T. brucei, L. donovani, L. infantum, P. falciferum and cytotoxicity assays provided a few significant to most potent compounds; two variant class of NTDs.

Keywords: 2-aminothiazole hybrid, antimalarial activity, anti-trypanosomal activity, anti-leishmanial activity, cytotoxicity studies, molecular docking simulatin.

[1]
Feasey, N.; Wansbrough-Jones, M.; Mabey, D.C.; Solomon, A.W. Neglected tropical diseases. Br. Med. Bull., 2010, 93(1), 179-200.
[http://dx.doi.org/10.1093/bmb/ldp046] [PMID: 20007668]
[2]
Hotez, P.J. Neglected infections of poverty in the United States of America. PLoS Negl. Trop. Dis., 2008, 2(6)e256
[http://dx.doi.org/10.1371/journal.pntd.0000256] [PMID: 18575621]
[3]
Edwards, J.A.; Kemski, M.M.; Rappleye, C.A. Identification of an aminothiazole with antifungal activity against intracellular Histoplasma capsulatum. Antimicrob. Agents Chemother., 2013, 57(9), 4349-4359.
[http://dx.doi.org/10.1128/AAC.00459-13] [PMID: 23817367]
[4]
Al-Balas, Q.; Anthony, N.G.; Al-Jaidi, B.; Alnimr, A.; Abbott, G.; Brown, A.K.; Taylor, R.C.; Besra, G.S.; McHugh, T.D.; Gillespie, S.H.; Johnston, B.F.; Mackay, S.P.; Coxon, G.D. Identification of 2-aminothiazole-4-carboxylate derivatives active against Mycobacterium tuberculosis H37Rv and the β-ketoacyl-ACP synthase mtFabH. PLoS One, 2009, 4(5)e5617
[http://dx.doi.org/10.1371/journal.pone.0005617] [PMID: 19440303]
[5]
Chong, W.K.M.; Duvadie, R.K.; Li, L.; Yang, Y. Antiproliferative 2-(heteroaryl)-aminothiazole compounds, pharmaceutical compositions and methods for their use; Google Patents, 2004.
[6]
Paquet, T.; Gordon, R.; Waterson, D.; Witty, M.J.; Chibale, K. Antimalarial aminothiazoles and aminopyridines from phenotypic whole-cell screening of a SoftFocus(®) library. Future Med. Chem., 2012, 4(18), 2265-2277.
[http://dx.doi.org/10.4155/fmc.12.176] [PMID: 23234550]
[7]
Cohen, F.E.; Du, X.; Guo, C.; McKerrow, J.H. Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use; Google Patents, 2005.
[8]
Jadav, S.S.; Kaptein, S.; Timiri, A.; De Burghgraeve, T.; Badavath, V.N.; Ganesan, R.; Sinha, B.N.; Neyts, J.; Leyssen, P.; Jayaprakash, V. Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors. Bioorg. Med. Chem. Lett., 2015, 25(8), 1747-1752.
[http://dx.doi.org/10.1016/j.bmcl.2015.02.059] [PMID: 25791449]
[9]
Mjambili, F.; Njoroge, M.; Naran, K.; De Kock, C.; Smith, P.J.; Mizrahi, V.; Warner, D.; Chibale, K. Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents. Bioorg. Med. Chem. Lett., 2014, 24(2), 560-564.
[http://dx.doi.org/10.1016/j.bmcl.2013.12.022] [PMID: 24373723]
[10]
Makam, P.; Thakur, P.K.; Kannan, T. In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives. Eur. J. Pharm. Sci., 2014, 52, 138-145.
[http://dx.doi.org/10.1016/j.ejps.2013.11.001] [PMID: 24231338]
[11]
Aher, R.B.; Roy, K. QSAR and pharmacophore modeling of diverse aminothiazoles and aminopyridines for antimalarial potency against multidrug-resistant Plasmodium falciparum. Med. Chem. Res., 2014, 23(9), 4238-4249.
[http://dx.doi.org/10.1007/s00044-014-0997-x]
[12]
Morde, V.A.; Shaikh, M.S.; Pissurlenkar, R.R.; Coutinho, E.C. Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors. Mol. Divers., 2009, 13(4), 501-517.
[http://dx.doi.org/10.1007/s11030-009-9141-0] [PMID: 19347595]
[13]
Mothana, R.A.; Al-Musayeib, N.M.; Matheeussen, A.; Cos, P.; Maes, L. Assessment of the in vitro antiprotozoal and cytotoxic potential of 20 selected medicinal plants from the island of Soqotra. Molecules, 2012, 17(12), 14349-14360.
[http://dx.doi.org/10.3390/molecules171214349] [PMID: 23208469]
[14]
Nath, C.; Badavath, V.N.; Thakur, A.; Ucar, G.; Acevedo, O.; Mohd Siddique, M.U.; Jayaprakash, V. Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A. MedChemComm, 2018, 9(7), 1164-1171.
[http://dx.doi.org/10.1039/C8MD00196K] [PMID: 30109004]
[15]
Badavath, V.N.; Jadav, S.S.; Pastorino, B.; De Lamballerie, X.; Sinha, B.N.; Jayaprakash, V. Synthesis and Antiviral Activity of 2-Aryl-4H-Chromen-4-One Derivatives against Chikungunya Virus. Lett. Drug Des. Discov., 2016, 13(10), 1019-1024.
[http://dx.doi.org/10.2174/1570180813666160711163349]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 2
Year: 2020
Page: [101 - 108]
Pages: 8
DOI: 10.2174/2211352516666181016122537

Article Metrics

PDF: 15
HTML: 2